{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:50:58Z","timestamp":1785336658865,"version":"3.55.0"},"reference-count":38,"publisher":"Kurume Medical Journal","issue":"1.2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kurume Med. J."],"published-print":{"date-parts":[[2024,6,30]]},"DOI":"10.2739\/kurumemedj.ms7112004","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T17:44:21Z","timestamp":1732643061000},"page":"11-18","source":"Crossref","is-referenced-by-count":1,"title":["High Expression of NDRG1 is a Poor Prognostic Factor in Patients with Endometrial Endometrioid Carcinoma with Long-Term Observation"],"prefix":"10.2739","volume":"71","author":[{"given":"MORIO","family":"IJICHI","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Yame General Hospital"},{"name":"Department of Obstetrics and Gynecology, Kurume University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KIMIO","family":"USHIJIMA","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOMOHIKO","family":"YAMAGUCHI","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Pathology, Kyushu University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NAOYO","family":"NISHIDA","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUTO","family":"TASAKI","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JONGMYUNG","family":"PARK","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHIN","family":"NISHIO","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOSHIHARU","family":"KAMURA","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JUN","family":"AKIBA","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kurume University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TATSUYUKI","family":"KAKUMA","sequence":"additional","affiliation":[{"name":"Biostatistics Center, Kurume University School of Medicine, Kurume University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHIHIKO","family":"KUWANO","sequence":"additional","affiliation":[{"name":"Cancer Translational Research Center, St. Mary\u2019s Institute of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NAOTAKE","family":"TSUDA","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1445","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Makker V, MacKay H, Ray-Coquard I, Levine DA, Westin SN et al. Endometrial cancer. Nat Rev Dis Primers 2021; 7:88.","DOI":"10.1038\/s41572-021-00324-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kaku T, Kamura T, Kinukawa N, Kobayashi H, Sakai K et al. Angiogenesis in endometrial carcinoma. Cancer 1997; 80:741-747.","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<741::AID-CNCR13>3.0.CO;2-T"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Berger AA, Dao F, and Levine DA. Angiogenesis in endometrial carcinoma: Therapies and biomarkers, current options, and future perspectives. Gynecol Oncol 2021; 160:844-850.","DOI":"10.1016\/j.ygyno.2020.12.016"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Roncolato F, Lindemann K, Willson ML, Martyn J, Mileshkin L et al. PI3K\/AKT\/mTOR inhibitors for advanced or recurrent endometrial cancer. Cochrane Database Syst Rev 2019; 10:CD012160.","DOI":"10.1002\/14651858.CD012160.pub2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Thiel KW, Devor EJ, Filiaci VL, Mutch D, Moxley K et al. TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology\/ Gynecologic Oncology Group Study. J Clin Oncol 2022; 40:3289-3300.","DOI":"10.1200\/JCO.21.02506"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Norquist BM, Brady MF, Harrell MI, Walsh T, Lee MK et al. Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology\/Gynecologic Oncology Group Study. Clin Cancer Res 2018; 24:777-783.","DOI":"10.1158\/1078-0432.CCR-17-1327"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Aghajanian C, Filiaci V, Dizon DS, Carlson JW, Powell MA et al. A phase II study of frontline paclitaxel\/carboplatin\/bevacizumab, paclitaxel\/carboplatin\/temsirolimus, or ixabepilone\/carboplatin\/ bevacizumab in advanced\/recurrent endometrial cancer. Gynecol Oncol 2018; 150:274-281.","DOI":"10.1016\/j.ygyno.2018.05.018"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Watari K, Shibata T, Fujita H, Shinoda A, Murakami Y et al. NDRG1 activates VEGF-A-induced angiogenesis through PLC\u03b31\/ERK signaling in mouse vascular endothelial cells. Commun Biol 2020; 3:107.","DOI":"10.1038\/s42003-020-0829-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fu Y, Wei J, Dai X, and Ye Y. Increased NDRG1 expression attenuate trophoblast invasion through ERK\/MMP-9 pathway in preeclampsia. Placenta 2017; 51:76-81.","DOI":"10.1016\/j.placenta.2017.01.126"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kokame K, Kato H, and Miyata T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78\/BiP and novel genes. J Biol Chem 1996; 271:29659-29665.","DOI":"10.1074\/jbc.271.47.29659"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Agarwala KL, Kokame K, Kato H, and Miyata T. Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein. Biochem Biophys Res Commun 2000; 272:641-647.","DOI":"10.1006\/bbrc.2000.2833"},{"key":"12","unstructured":"12. Belzen NV, Dinjens WN, Diesveld MP, Groen NA, van der Made AC et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 1997; 77:85-92."},{"key":"13","unstructured":"13. Kurdistani SK, Arizti P, Reimer CL, Sugrue MM, Aaronson SA et al. Inhibition of tumor cell growth by RTP\/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 1998; 58:4439-4444."},{"key":"14","unstructured":"14. Zhou D, Salnikow K, and Costa M. Cap43, a novel gene specifically induced by Ni2+ compounds. Cancer Res 1998; 58:2182-2189."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Shimono A, Okuda T, and Kondoh H. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 1999; 83:39-52.","DOI":"10.1016\/S0925-4773(99)00025-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lin TM and Chang C. Cloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone, Proc Natl Acad Sci U S A 1997; 94:4988-4993.","DOI":"10.1073\/pnas.94.10.4988"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sato N, Kokame K, Shimokado K, Kato H, and Miyata T. Changes of gene expression by lysophosphatidylcholine in vascular endothelial cells: 12 up-regulated distinct genes including 5 cell growth-related, 3 thrombosis-related, and 4 others. J Biochem 1998; 123:1119-1126.","DOI":"10.1093\/oxfordjournals.jbchem.a022051"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Salnikow K, Kluz T, and Costa M. Role of Ca (2+) in the regulation of nickel-inducible Cap43 gene expression. Toxicol Appl Pharmacol 1999; 160:127-132.","DOI":"10.1006\/taap.1999.8759"},{"key":"19","unstructured":"19. Salnikow K, Blagosklonny MV, Ryan H, Johnson R, and Costa M Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res 2000; 60:38-41."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Xu B, Lin L, and Rote NS. Identification of a stress-induced protein during human trophoblast differentiation by differential display analysis. Biol Reprod 1999; 61:681-686.","DOI":"10.1095\/biolreprod61.3.681"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV et al. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 2004; 279:48930-48940.","DOI":"10.1074\/jbc.M400386200"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Joshi V, Lakhani SR, and Reed McCart AE. NDRG1 in Cancer: A Suppressor, Promoter, or Both? Cancers 2022; 14:5739.","DOI":"10.3390\/cancers14235739"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Fotovati A, Fujii T, Yamaguchi M, Kage M, Shirouzu K et al. 17Beta-estradiol induces down-regulation of Cap43\/NDRG1\/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells. Clin Cancer Res 2006; 12:3010-3018.","DOI":"10.1158\/1078-0432.CCR-05-1962"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Azuma K, Kawahara A, Hattori S, Taira T, Tsurutani J et al. NDRG1\/Cap43\/Drg-1 may Predict Tumor Angiogenesis and Poor Outcome in Patients with Lung Cancer. J Thorac Oncol 2012; 7:779-789.","DOI":"10.1097\/JTO.0b013e31824c92b4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Weidner N, Semple JP, Welch WR, and Folkman J. Tumor angiogenesis and metastasis \u2013 correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.","DOI":"10.1056\/NEJM199101033240101"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN et al. Gasparini G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84:1875-1887.","DOI":"10.1093\/jnci\/84.24.1875"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nishio S, Ushijima K, Tsuda N, Takemoto S, Kawano K et al. Cap43\/NDRG1\/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Lett 2008; 264:36-43.","DOI":"10.1016\/j.canlet.2008.01.020"},{"key":"28","unstructured":"28. H Xu, X Sun, and W-J Sun. Expression and clinical correlation of NGAL and VEGF in endometrial carcinoma. Eur Rev Med Pharmacy Sci 2018; 22:632-636."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Chen J, Li S, Yang Z, Lu G, and Hu H. Correlation between NDRG1 and PTEN expression in endometrial carcinoma. Cancer Sci 2008; 99:706-710.","DOI":"10.1111\/j.1349-7006.2008.00749.x"},{"key":"30","unstructured":"30. Li S, Chen J, Yang Z, Lu G, Tang H et al. N-myc downstream-regulated gene 1 as a downregulated target gene of PTEN in the controlling of tumourigenesis in endometrioid carcinoma. Indian J Med Res 2008; 127:453-459."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43\/NDRG1\/Drg-1 through modulation of angiogenesis.Cancer Res 2006; 66:6233-6242.","DOI":"10.1158\/0008-5472.CAN-06-0183"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Malette B, Cherry E, Lagac\u00e9 M, Bernard M, Gosselin D et al. Large scale validation of human N-myc downstream-regulated gene (NDRG)-1 expression in endometrium during the menstrual cycle. Mol Hum Reprod 2003; 9(11):671-679.","DOI":"10.1093\/molehr\/gag084"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Lv XH, Chen JW, Zhao G, Feng ZZ, Yang DH et al. N-myc downstream-regulated gene 1\/Cap43 may function as tumor suppressor in endometrial cancer. J Cancer Res Clin Oncol 2012; 138(10):1703-1715.","DOI":"10.1007\/s00432-012-1249-4"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Wu AY, Hu Y, Cang W, Li D, Wang WJ et al. Suppressive effect of microRNA-449a on the NDRG1\/PTEN\/AKT axis regulates endometrial cancer growth and metastasis. Exp Cell Res 2019; 382:111468.","DOI":"10.1016\/j.yexcr.2019.06.013"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Bhyan SB, Wee Y, Liu Y, Cummins S, and Zhao M. Integrative analysis of common genes and driver mutations implicated in hormone stimulation for four cancers in women. PeerJ 2019; 7:e6872.","DOI":"10.7717\/peerj.6872"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Lv XH, Chen JW, Zhao G, Feng ZZ, Yang DH et al. N-myc downstream-regulated gene 1\/Cap43 may function as tumor suppressor in endometrial cancer. J Cancer Res Clin Oncol 2012; 138:1703-1715.","DOI":"10.1007\/s00432-012-1249-4"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Wu AY, Hu Y, Cang W, Li D, Wang WJ et al. Suppressive effect of microRNA-449a on the NDRG1\/PTEN\/AKT axis regulates endometrial cancer growth and metastasis. Exp Cell Res 2019; 382:111468.","DOI":"10.1016\/j.yexcr.2019.06.013"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Yen TT, Wang TL, Fader AN, Shih IM, and Gaillard S. Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer. Int J Gynecol Pathol 2020; 39:26-35.","DOI":"10.1097\/PGP.0000000000000585"}],"container-title":["The Kurume Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/71\/1.2\/71_MS7112004\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:54:17Z","timestamp":1754110457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/71\/1.2\/71_MS7112004\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,30]]},"references-count":38,"journal-issue":{"issue":"1.2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2739\/kurumemedj.ms7112004","relation":{},"ISSN":["0023-5679","1881-2090"],"issn-type":[{"value":"0023-5679","type":"print"},{"value":"1881-2090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,30]]},"article-number":"MS7112004"}}